Purchase Order 1281J819P0007
- Not listed
- This federal contract award was made by a civilian federal agency to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for the purchase of scientific consumables, such as DNA/RNA extraction kits, next-generation sequencing equipment, and bioinformatics software, with a ceiling value of $6,162.64. The contract is a firm fixed-price purchase order without a set-aside designation, indicating Qiagen's ability to compete effectively in the federal...
- This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The $11,343.80 firm fixed-price purchase order is for QIASEQ TARGETED DNA CUSTOM PANEL (96) - 6601-6700, CDHS-47388Z-6699 products. The contract has an ultimate completion date of September 27, 2025. Qiagen, LLC is a division of the international biotechnology...
- This federal contract award was made by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The $12,332.71 firm fixed-price purchase order is for the delivery of Qiagen's products and services, which likely include DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, precision medicine analysis...
- This federal contract award extends a service agreement with Qiagen, LLC, a subsidiary of Qiagen N.V., a global biotechnology company. The $12,063 firm fixed-price purchase order was awarded by the Pacific West Area of a civilian federal agency. The contract has a one-year period of performance, with a completion date of September 28, 2024. No set-aside designation was used. Qiagen is a long-standing provider of specialized products and services to support federal agencies' biomedical...
- This is a $211,853.58 firm fixed-price purchase order awarded by the Defense Health Agency to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, laboratory equipment, and bioinformatics software. The contract is for QCII ONE PRECUR 301-600 TESTING, with a period of performance through May 31, 2027. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which has a significant federal contract portfolio supporting biomedical research,...
- This federal contract award is for laboratory equipment and supplies provided by Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract, with a ceiling value of $27,785.90, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services. The contract is a firm fixed-price purchase order with a completion date of June 17, 2016. This award is not associated with a set-aside program....
- The U.S. federal government awarded a Firm Fixed Price Purchase Order contract worth $22,732.35 to Qiagen, LLC, a division of the international company Qiagen N.V., for the provision of DNA isolation kits. The contract has an ultimate completion date of June 1, 2018 and was awarded on May 3, 2018 by the Acquisitions agency, which is a civilian agency. Qiagen, LLC is a foreign-owned, for-profit manufacturer that has provided various products and services to support federal agencies' biomedical...
- This is a federal contract award from the Department of Justice Federal Bureau of Investigation Headquarters Division to Qiagen, LLC, a division of Qiagen N.V. The contract is a Firm Fixed Price Delivery Order with a potential value of $142,305.36. The contract is for the second option year and has a completion date of June 21, 2021. Qiagen is a manufacturer of goods and a foreign-owned for-profit organization that provides products and services to support federal agencies' biomedical...
- Qiagen, LLC received a $14,706 Firm Fixed Price contract award on November 8, 2017, through a Blanket Purchase Agreement (BPA) call with the Office of Logistics and Acquisition Operations, a civilian agency. The contract is classified as an "In Vitro" procurement with an ultimate completion date of April 30, 2018, and will be performed in Germantown, Maryland. No set-aside designation was applied to this award, indicating open competitive procurement. As a foreign-owned molecular...
- This federal contract award is to QIAGEN INC, a division of the international biotechnology company QIAGEN N.V., for $4,887.30. The contract is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing type, awarded by the Office of the Chief Operating Officer, a civilian agency. The contract is for the delivery of molecular diagnostics products and services, including DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation...
This federal contract award is for a full service agreement for a QIAGILITY instrument (serial number 8461) from QIAGEN, LLC, a subsidiary of the Dutch biotechnology company QIAGEN N.V. The contract has a ceiling value of $24,842.00 and is a firm fixed price purchase order that covers year one with four optional extension years. The contract was awarded on September 30, 2019 by a civilian federal agency, with a performance location in Maricopa, Arizona. The contract does not utilize any set-aside designations. QIAGEN, LLC is a foreign-owned, for-profit manufacturer that provides a range of molecular diagnostics products and services to various government agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Veterans Affairs, and Federal Bureau of Investigation. QIAGEN holds several significant indefinite delivery vehicles with these agencies for its specialized scientific equipment, reagents, and bioinformatics software.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Exercise an Option | $4.5k | 7/31/20 | |
| Not listed | Not listed | $6.9k | 9/30/19 |